These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30091680)

  • 21. A Comparison of Atrial Fibrillation Monitoring Strategies After Cryptogenic Stroke (from the Cryptogenic Stroke and Underlying AF Trial).
    Choe WC; Passman RS; Brachmann J; Morillo CA; Sanna T; Bernstein RA; Di Lazzaro V; Diener HC; Rymer MM; Beckers F; Koehler J; Ziegler PD;
    Am J Cardiol; 2015 Sep; 116(6):889-93. PubMed ID: 26183793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and Future Use of Insertable Cardiac Monitors.
    Giancaterino S; Lupercio F; Nishimura M; Hsu JC
    JACC Clin Electrophysiol; 2018 Nov; 4(11):1383-1396. PubMed ID: 30466842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insertable cardiac monitors in the diagnosis of syncope and the detection of atrial fibrillation: A systematic review and meta-analysis.
    Burkowitz J; Merzenich C; Grassme K; Brüggenjürgen B
    Eur J Prev Cardiol; 2016 Aug; 23(12):1261-72. PubMed ID: 26864396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic evaluation of extended electrocardiogram monitoring for atrial fibrillation in patients with cryptogenic stroke.
    Chew DS; Rennert-May E; Quinn FR; Buck B; Hill MD; Spackman E; Manns BJ; Exner DV
    Int J Stroke; 2021 Oct; 16(7):809-817. PubMed ID: 33232196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial fibrillation and paroxysmal atrial fibrillation detection in patients with acute ischemic stroke.
    Sutamnartpong P; Dharmasaroja PA; Ratanakorn D; Arunakul I
    J Stroke Cerebrovasc Dis; 2014; 23(5):1138-41. PubMed ID: 24189453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Covert Atrial Fibrillation in Cryptogenic Ischemic Stroke: Current Clinical Practice in Japan.
    Toyoda K; Okumura K; Hashimoto Y; Ikeda T; Komatsu T; Hirano T; Fukuda H; Matsumoto K; Yasaka M
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1829-37. PubMed ID: 27282299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between Bilateral Infarcts Pattern and Detection of Occult Atrial Fibrillation in Embolic Stroke of Undetermined Source (ESUS) Patients with Insertable Cardiac Monitor (ICM).
    Yushan B; Tan BYQ; Ngiam NJ; Chan BPL; Luen TH; Sharma VK; Sia CH; Dalakoti M; Chong SS; Kojodjojo P; Yeo LLL
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2448-2452. PubMed ID: 31307898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insertable cardiac monitors: current indications and devices.
    Sakhi R; Theuns DAMJ; Szili-Torok T; Yap SC
    Expert Rev Med Devices; 2019 Jan; 16(1):45-55. PubMed ID: 30522350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.
    Benezet-Mazuecos J; Rubio JM; Cortés M; Iglesias JA; Calle S; de la Vieja JJ; Quiñones MA; Sanchez-Borque P; de la Cruz E; Espejo A; Farré J
    Europace; 2015 Mar; 17(3):364-9. PubMed ID: 25336664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of short ECG recordings twice daily to detect paroxysmal atrial fibrillation in stroke and transient ischemic attack patients.
    Poulsen MB; Binici Z; Dominguez H; Soja AM; Kruuse C; Hornnes AH; Rasmussen RS; Overgaard K
    Int J Stroke; 2017 Feb; 12(2):192-196. PubMed ID: 27694312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors.
    Ungar A; Pescini F; Rafanelli M; De Angelis MV; Faustino M; Tomaselli C; Petrone A; Forleo G; Morani G; Forlivesi S; Molon G; Adami A; Maines M; Stegagno C; Poggesi A; Pantoni L
    Eur J Intern Med; 2021 Oct; 92():86-93. PubMed ID: 34247889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors.
    Ritter MA; Kochhäuser S; Duning T; Reinke F; Pott C; Dechering DG; Eckardt L; Ringelstein EB
    Stroke; 2013 May; 44(5):1449-52. PubMed ID: 23449264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
    Waks JW; Passman RS; Matos J; Reynolds M; Thosani A; Mela T; Pederson D; Glotzer TV; Zimetbaum P
    Heart Rhythm; 2018 Nov; 15(11):1601-1607. PubMed ID: 29981863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study.
    Reiffel JA; Verma A; Kowey PR; Halperin JL; Gersh BJ; Wachter R; Pouliot E; Ziegler PD;
    JAMA Cardiol; 2017 Oct; 2(10):1120-1127. PubMed ID: 28842973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P-wave evidence as a method for improving algorithm to detect atrial fibrillation in insertable cardiac monitors.
    Pürerfellner H; Pokushalov E; Sarkar S; Koehler J; Zhou R; Urban L; Hindricks G
    Heart Rhythm; 2014 Sep; 11(9):1575-83. PubMed ID: 24912139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease management: atrial fibrillation and home monitoring.
    Ricci RP
    Europace; 2013 Jun; 15 Suppl 1():i35-i39. PubMed ID: 23737228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
    Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
    Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insertable cardiac monitors after cryptogenic stroke--a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation.
    Poli S; Diedler J; Härtig F; Götz N; Bauer A; Sachse T; Müller K; Müller I; Stimpfle F; Duckheim M; Steeg M; Eick C; Schreieck J; Gawaz M; Ziemann U; Zuern CS
    Eur J Neurol; 2016 Feb; 23(2):375-81. PubMed ID: 26470854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices.
    DeCicco AE; Finkel JB; Greenspon AJ; Frisch DR
    Heart Rhythm; 2014 Apr; 11(4):719-24. PubMed ID: 24394157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
    Di Cori A; Lilli A; Zucchelli G; Zaca V
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.